Table 3

Multivariate Cox regression analysis of patients with MDS/MPN-U

VariablesOSAMLFS
HR (95% CI)P valueHR (95% CI)P value
LDH (increased) 2.00 (0.90-4.44) .0873 1.81 (0.86-3.79) .1163 
WBC ≥40 × 109/dL 1.91 (0.64-5.69) .2446 2.62 (0.96-7.13) .0583 
Platelets ≥ 450 × 109/dL – – – – 
 100-450 1.05 (0.43-2.56) .9127 0.71 (0.30-1.66) .4328 
 <100 1.82 (0.67-4.91) .2330 1.10 (0.42-2.86) .8372 
 <100 vs 100-450 1.73 (0.71-4.22) .2234 1.55 (0.66-3.64) .3128 
Blood myeloid precursors ≥10% 1.57 (0.44-5.56) .4815 3.19 (0.91-11.10) .0677 
BM blasts ≥5% 2.02 (0.81-5.01) .1264 2.60 (1.13-5.98) .0242 
PB blasts ≥5% 0.35 (0.10-1.25) .1076 0.17 (0.04-0.68) .0125 
Cytogenetics 3* 7.24 (1.60-32.68) .0100 76.62 (10.21-574.66) <.0001 
Dysgranulopoiesis 1.18 (0.49-2.83) .7048 1.48 (0.62-3.53) .3704 
VariablesOSAMLFS
HR (95% CI)P valueHR (95% CI)P value
LDH (increased) 2.00 (0.90-4.44) .0873 1.81 (0.86-3.79) .1163 
WBC ≥40 × 109/dL 1.91 (0.64-5.69) .2446 2.62 (0.96-7.13) .0583 
Platelets ≥ 450 × 109/dL – – – – 
 100-450 1.05 (0.43-2.56) .9127 0.71 (0.30-1.66) .4328 
 <100 1.82 (0.67-4.91) .2330 1.10 (0.42-2.86) .8372 
 <100 vs 100-450 1.73 (0.71-4.22) .2234 1.55 (0.66-3.64) .3128 
Blood myeloid precursors ≥10% 1.57 (0.44-5.56) .4815 3.19 (0.91-11.10) .0677 
BM blasts ≥5% 2.02 (0.81-5.01) .1264 2.60 (1.13-5.98) .0242 
PB blasts ≥5% 0.35 (0.10-1.25) .1076 0.17 (0.04-0.68) .0125 
Cytogenetics 3* 7.24 (1.60-32.68) .0100 76.62 (10.21-574.66) <.0001 
Dysgranulopoiesis 1.18 (0.49-2.83) .7048 1.48 (0.62-3.53) .3704 
*

Cytogenetic category 3 (complex and −7/−7q) is compared with category 1 (normal or –Y) combined with category 2 (all other abnormalities).

Close Modal

or Create an Account

Close Modal
Close Modal